Video thumbnail for Moderna Stock Drops 15% as Slashed Guidance Highlights Weak EU Sales and Tough U.S. Vaccine Market

Moderna Stock Drops 15% as Slashed Guidance Highlights Weak EU Sales and Tough U.S. Vaccine Market

Aug 1, 2024
techgeeksblogs Logo

techgeeksblogs

Moderna Stock Drops 15% as Slashed Guidance Highlights Weak EU Sales and Tough U.S. Vaccine Market
#Business & Industrial #Pharmaceuticals & Biotech #Public Health